iStent & iStent Inject Cost in UK
iStent and iStent Inject are among the most widely used Minimally Invasive Glaucoma Surgery (MIGS) devices available today. Designed for patients with mild to moderate open-angle glaucoma, these tiny stents improve fluid drainage and help lower intraocular pressure (IOP), often reducing or eliminating the need for daily eye drops.
Average iStent Surgery Cost in UK
The cost of iStent surgery in the UK can vary depending on whether you are treated in an NHS hospital or a private clinic.
-
NHS Coverage: In many cases, iStent is available through NHS hospitals for eligible patients, meaning the cost is covered by public health services.
-
Private Clinics: Prices in private hospitals range between £2,000 – £3,500 per eye, depending on surgeon fees, facility charges, and whether it is combined with cataract surgery.
Procedure and Recovery
iStent is usually performed during cataract surgery and takes just a few minutes. Recovery is typically fast, with patients resuming normal activities within days. Most report improved eye pressure control and a reduced reliance on glaucoma medications.
Explore detailed glaucoma surgery costs and what affects pricing in UK hospitals.
Benefits of iStent & iStent Inject
-
Minimally invasive: No large incisions or sutures required
-
Reduced medication dependence: Many patients can lower or stop using daily drops
-
Low complication rate: Safer than traditional filtering surgery
-
Fast recovery: Minimal downtime compared to trabeculectomy
Ideal Candidates
iStent is ideal for:
-
Patients with mild to moderate open-angle glaucoma
-
Individuals undergoing cataract surgery who want additional IOP reduction
-
Patients seeking a lower-risk alternative to major glaucoma surgery
Risks and Considerations
Though iStent is considered safe, there are potential risks, including:
-
Device misplacement or obstruction
-
Need for additional glaucoma surgery if IOP remains uncontrolled
-
Rare risk of eye inflammation or infection
Long-Term Outlook
Clinical studies show that iStent can maintain lower eye pressure for years, though some patients may eventually require additional treatment. Regular monitoring by an ophthalmologist is crucial to track disease progression.
